A
$ Value
$1K
Shares
6
Price
$189
Filed
Oct 24
Insider
Name
CARTER ROBERT B
Title
—
CIK
0001197607
Roles
Director
Transaction Details
Transaction Date
2025-10-21
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,698
Footnotes
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Filing Info
CARTER ROBERT B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | DGX | L | $1K |
| 2025-10-21 | DGX | A | $1K |
| 2025-07-21 | DGX | L | $1K |
| 2025-05-15 | DGX | A | $0 |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $1.2M | 2026-02-10 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $5.7M | 2026-02-19 |
|
Davis J. E.
CEO and President
|
— | — | 2026-02-18 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-02-18 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | — | 2026-02-18 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-02-18 |